1. Introduction
    1.1. Objectives of the Study
    1.2. Market Definition
    1.3. Research Scope
    1.4. Currency
    1.5. Key Target Audience

2. Research Methodology and Assumptions

3. Executive Summary

4. Premium Insights
    4.1. Porter’s Five Forces Analysis
    4.2. Value Chain Analysis
    4.3. Top Investment Pockets
          4.3.1. Market Attractiveness Analysis By Detection Target
          4.3.2. Market Attractiveness Analysis By Test Technique
          4.3.3. Market Attractiveness Analysis By End-User
          4.3.4. Market Attractiveness Analysis By Test Type
          4.3.5. Market Attractiveness Analysis By Region
    4.4. Industry Trends

5. Market Dynamics
    5.1. Market Evaluation
    5.2. Drivers
          5.2.1. The increasing investment by government and private organizations in MRD research
          5.2.2. The growing prevalence of different types of cancer worldwide
          5.2.3. The increasing consumer awareness for tailored therapy
    5.3. Restraints
          5.3.1. The high cost of research and development activities
    5.4. Opportunities
          5.4.1. The rise in the personalized medicines for the treatment
          5.4.2. The rise in the collaborations for product development
    5.5. Challenges
          5.5.1. The lack of trained professionals and unavailability centres

6. Global Minimal Residual Disease Market Analysis and Forecast, By Detection Target
    6.1. Segment Overview
    6.2. Lymphoma
    6.3. Leukemia
    6.4. Solid Tumors
    6.5. Others

7. Global Minimal Residual Disease Market Analysis and Forecast, By Test Technique
    7.1. Segment Overview
    7.2. Fluorescence in Situ Hybridization (FISH)
    7.3. Polymerase Chain Reaction (PCR)
    7.4. Next Generation Sequencing (NGS)

8. Global Minimal Residual Disease Market Analysis and Forecast, By End-User
    8.1. Segment Overview
    8.2. Hospitals
    8.3. Specialty Clinics
    8.4. Laboratory Centers

9. Global Minimal Residual Disease Market Analysis and Forecast, By Test Type
    9.1. Segment Overview
    9.2. RNA-Based Test
    9.3. DNA-Based Test
    9.4. Immunological Test

10. Global Minimal Residual Disease Market Analysis and Forecast, By Regional Analysis
    10.1. Segment Overview
    10.2. North America
          10.2.1. U.S.
          10.2.2. Canada
          10.2.3. Mexico
    10.3. Europe
          10.3.1. Germany
          10.3.2. France
          10.3.3. U.K.
          10.3.4. Italy
          10.3.5. Spain
    10.4. Asia-Pacific
          10.4.1. Japan
          10.4.2. China
          10.4.3. India
    10.5. South America
          10.5.1. Brazil
    10.6. Middle East and Africa
          10.6.1. UAE
          10.6.2. South Africa

11. Global Minimal Residual Disease Market-Competitive Landscape
    11.1. Overview
    11.2. Market Share of Key Players in Global Minimal Residual Disease Market
          11.2.1. Global Company Market Share
          11.2.2. North America Company Market Share
          11.2.3. Europe Company Market Share
          11.2.4. APAC Company Market Share
    11.3. Competitive Situations and Trends
          11.3.1. Product Launches and Developments
          11.3.2. Partnerships, Collaborations, and Agreements
          11.3.3. Mergers & Acquisitions
          11.3.4. Expansions

12. Company Profiles
    12.1. Sysmex Corporation
          12.1.1. Business Overview
          12.1.2. Company Snapshot
          12.1.3. Company Market Share Analysis
          12.1.4. Company Product Portfolio
          12.1.5. Recent Developments
          12.1.6. SWOT Analysis
    12.2. ArcherDX(Invitae)
          12.2.1. Business Overview
          12.2.2. Company Snapshot
          12.2.3. Company Market Share Analysis
          12.2.4. Company Product Portfolio
          12.2.5. Recent Developments
          12.2.6. SWOT Analysis
    12.3. ICON plc
          12.3.1. Business Overview
          12.3.2. Company Snapshot
          12.3.3. Company Market Share Analysis
          12.3.4. Company Product Portfolio
          12.3.5. Recent Developments
          12.3.6. SWOT Analysis
    12.4. Asuragen
          12.4.1. Business Overview
          12.4.2. Company Snapshot
          12.4.3. Company Market Share Analysis
          12.4.4. Company Product Portfolio
          12.4.5. Recent Developments
          12.4.6. SWOT Analysis
    12.5. Mission Bio
          12.5.1. Business Overview
          12.5.2. Company Snapshot
          12.5.3. Company Market Share Analysis
          12.5.4. Company Product Portfolio
          12.5.5. Recent Developments
          12.5.6. SWOT Analysis
    12.6. ARUP Laboratories
          12.6.1. Business Overview
          12.6.2. Company Snapshot
          12.6.3. Company Market Share Analysis
          12.6.4. Company Product Portfolio
          12.6.5. Recent Developments
          12.6.6. SWOT Analysis
    12.7. Guardant Health
          12.7.1. Business Overview
          12.7.2. Company Snapshot
          12.7.3. Company Market Share Analysis
          12.7.4. Company Product Portfolio
          12.7.5. Recent Developments
          12.7.6. SWOT Analysis
    12.8. Cergentis B.V.
          12.8.1. Business Overview
          12.8.2. Company Snapshot
          12.8.3. Company Market Share Analysis
          12.8.4. Company Product Portfolio
          12.8.5. Recent Developments
          12.8.6. SWOT Analysis
    12.9. Invivoscribe
          12.9.1. Business Overview
          12.9.2. Company Snapshot
          12.9.3. Company Market Share Analysis
          12.9.4. Company Product Portfolio
          12.9.5. Recent Developments
          12.9.6. SWOT Analysis
    12.10. NeoGenomics Laboratories
          12.10.1. Business Overview
          12.10.2. Company Snapshot
          12.10.3. Company Market Share Analysis
          12.10.4. Company Product Portfolio
          12.10.5. Recent Developments
          12.10.6. SWOT Analysis
    12.11. Bio-Rad Laboratories
          12.11.1. Business Overview
          12.11.2. Company Snapshot
          12.11.3. Company Market Share Analysis
          12.11.4. Company Product Portfolio
          12.11.5. Recent Developments
          12.11.6. SWOT Analysis
    12.12. Opko Health
          12.12.1. Business Overview
          12.12.2. Company Snapshot
          12.12.3. Company Market Share Analysis
          12.12.4. Company Product Portfolio
          12.12.5. Recent Developments
          12.12.6. SWOT Analysis
    12.13. LabCorp
          12.13.1. Business Overview
          12.13.2. Company Snapshot
          12.13.3. Company Market Share Analysis
          12.13.4. Company Product Portfolio
          12.13.5. Recent Developments
          12.13.6. SWOT Analysis
    12.14. Adaptive Biotechnologies
          12.14.1. Business Overview
          12.14.2. Company Snapshot
          12.14.3. Company Market Share Analysis
          12.14.4. Company Product Portfolio
          12.14.5. Recent Developments
          12.14.6. SWOT Analysis
    12.15. Natera
          12.15.1. Business Overview
          12.15.2. Company Snapshot
          12.15.3. Company Market Share Analysis
          12.15.4. Company Product Portfolio
          12.15.5. Recent Developments
          12.15.6. SWOT Analysis
    12.16. Inivata
          12.16.1. Business Overview
          12.16.2. Company Snapshot
          12.16.3. Company Market Share Analysis
          12.16.4. Company Product Portfolio
          12.16.5. Recent Developments
          12.16.6. SWOT Analysis
    12.17. Sysmex Corporation
          12.17.1. Business Overview
          12.17.2. Company Snapshot
          12.17.3. Company Market Share Analysis
          12.17.4. Company Product Portfolio
          12.17.5. Recent Developments
          12.17.6. SWOT Analysis
    12.18. Quest Diagnostics
          12.18.1. Business Overview
          12.18.2. Company Snapshot
          12.18.3. Company Market Share Analysis
          12.18.4. Company Product Portfolio
          12.18.5. Recent Developments
          12.18.6. SWOT Analysis
 

List of Table

1. Global Minimal Residual Disease Market, By Detection Target, 2019-2030 (USD Million)

2. Global Lymphoma, Minimal Residual Disease Market, By Region, 2019-2030 (USD Million) 

3. Global Leukemia, Minimal Residual Disease Market, By Region, 2019-2030 (USD Million) 

4. Global Solid Tumors, Minimal Residual Disease Market, By Region, 2019-2030 (USD Million) 

5. Global Others, Minimal Residual Disease Market, By Region, 2019-2030 (USD Million) 

6. Global Minimal Residual Disease Market, By Test Technique, 2019-2030 (USD Million)

7. Global Fluorescence in Situ Hybridization (FISH), Minimal Residual Disease Market, By Region, 2019-2030 (USD Million)

8. Global Polymerase Chain Reaction (PCR), Minimal Residual Disease Market, By Region, 2019-2030 (USD Million)

9. Global Next Generation Sequencing (NGS), Minimal Residual Disease Market, By Region, 2019-2030 (USD Million)

10. Global Minimal Residual Disease Market, By End-User, 2019-2030 (USD Million)

11. Global Hospitals, Minimal Residual Disease Market, By Region, 2019-2030 (USD Million)

12. Global Specialty Clinics, Minimal Residual Disease Market, By Region, 2019-2030 (USD Million)

13. Global Laboratory Centers, Minimal Residual Disease Market, By Region, 2019-2030 (USD Million)

14. Global Minimal Residual Disease Market, By Test Type, 2019-2030 (USD Million)

15. Global RNA-Based Test, Minimal Residual Disease Market, By Region, 2019-2030 (USD Million)

16. Global DNA-Based Test, Minimal Residual Disease Market, By Region, 2019-2030 (USD Million)

17. Global Immunological Test, Minimal Residual Disease Market, By Region, 2019-2030 (USD Million)

18. North America Minimal Residual Disease Market, By Detection Target, 2019-2030 (USD Million)

19. North America Minimal Residual Disease Market, By Test Technique, 2019-2030 (USD Million)

20. North America Minimal Residual Disease Market, By End-User, 2019-2030 (USD Million)

21. North America Minimal Residual Disease Market, By Test Type, 2019-2030 (USD Million)

22. U.S. Minimal Residual Disease Market, By Detection Target, 2019-2030 (USD Million)

23. U.S. Minimal Residual Disease Market, By Test Technique, 2019-2030 (USD Million)

24. U.S. Minimal Residual Disease Market, By End-User, 2019-2030 (USD Million)

25. U.S. Minimal Residual Disease Market, By Test Type, 2019-2030 (USD Million)

26. Canada Minimal Residual Disease Market, By Detection Target, 2019-2030 (USD Million)

27. Canada Minimal Residual Disease Market, By Test Technique, 2019-2030 (USD Million)

28. Canada Minimal Residual Disease Market, By End-User, 2019-2030 (USD Million)

29. Canada Minimal Residual Disease Market, By Test Type, 2019-2030 (USD Million)

30. Mexico Minimal Residual Disease Market, By Detection Target, 2019-2030 (USD Million)

31. Mexico Minimal Residual Disease Market, By Test Technique, 2019-2030 (USD Million)

32. Mexico Minimal Residual Disease Market, By End-User, 2019-2030 (USD Million)

33. Mexico Minimal Residual Disease Market, By Test Type, 2019-2030 (USD Million)

34. Europe Minimal Residual Disease Market, By Detection Target, 2019-2030 (USD Million)

35. Europe Minimal Residual Disease Market, By Test Technique, 2019-2030 (USD Million)

36. Europe Minimal Residual Disease Market, By End-User, 2019-2030 (USD Million)

37. Europe Minimal Residual Disease Market, By Test Type, 2019-2030 (USD Million)

38. Germany Minimal Residual Disease Market, By Detection Target, 2019-2030 (USD Million)

39. Germany Minimal Residual Disease Market, By Test Technique, 2019-2030 (USD Million)

40. Germany Minimal Residual Disease Market, By End-User, 2019-2030 (USD Million)

41. Germany Minimal Residual Disease Market, By Test Type, 2019-2030 (USD Million)

42. France Minimal Residual Disease Market, By Detection Target, 2019-2030 (USD Million)

43. France Minimal Residual Disease Market, By Test Technique, 2019-2030 (USD Million)

44. France Minimal Residual Disease Market, By End-User, 2019-2030 (USD Million)

45. France Minimal Residual Disease Market, By Test Type, 2019-2030 (USD Million)

46. U.K. Minimal Residual Disease Market, By Detection Target, 2019-2030 (USD Million)

47. U.K. Minimal Residual Disease Market, By Test Technique, 2019-2030 (USD Million)

48. U.K. Minimal Residual Disease Market, By End-User, 2019-2030 (USD Million)

49. U.K. Minimal Residual Disease Market, By Test Type, 2019-2030 (USD Million)

50. Italy Minimal Residual Disease Market, By Detection Target, 2019-2030 (USD Million)

51. Italy Minimal Residual Disease Market, By Test Technique, 2019-2030 (USD Million)

52. Italy Minimal Residual Disease Market, By End-User, 2019-2030 (USD Million)

53. Italy Minimal Residual Disease Market, By Test Type, 2019-2030 (USD Million)

54. Spain Minimal Residual Disease Market, By Detection Target, 2019-2030 (USD Million)

55. Spain Minimal Residual Disease Market, By Test Technique, 2019-2030 (USD Million)

56. Spain Minimal Residual Disease Market, By End-User, 2019-2030 (USD Million)

57. Spain Minimal Residual Disease Market, By Test Type, 2019-2030 (USD Million)

58. Asia Pacific Minimal Residual Disease Market, By Detection Target, 2019-2030 (USD Million)

59. Asia Pacific Minimal Residual Disease Market, By Test Technique, 2019-2030 (USD Million)

60. Asia Pacific Minimal Residual Disease Market, By End-User, 2019-2030 (USD Million)

61. Asia Pacific Minimal Residual Disease Market, By Test Type, 2019-2030 (USD Million)

62. Japan Minimal Residual Disease Market, By Detection Target, 2019-2030 (USD Million)

63. Japan Minimal Residual Disease Market, By Test Technique, 2019-2030 (USD Million)

64. Japan Minimal Residual Disease Market, By End-User, 2019-2030 (USD Million)

65. Japan Minimal Residual Disease Market, By Test Type, 2019-2030 (USD Million)

66. China Minimal Residual Disease Market, By Detection Target, 2019-2030 (USD Million)

67. China Minimal Residual Disease Market, By Test Technique, 2019-2030 (USD Million)

68. China Minimal Residual Disease Market, By End-User, 2019-2030 (USD Million)

69. China Minimal Residual Disease Market, By Test Type, 2019-2030 (USD Million)

70. India Minimal Residual Disease Market, By Detection Target, 2019-2030 (USD Million)

71. India Minimal Residual Disease Market, By Test Technique, 2019-2030 (USD Million)

72. India Minimal Residual Disease Market, By End-User, 2019-2030 (USD Million)

73. India Minimal Residual Disease Market, By Test Type, 2019-2030 (USD Million)

74. South America Minimal Residual Disease Market, By Detection Target, 2019-2030 (USD Million)

75. South America Minimal Residual Disease Market, By Test Technique, 2019-2030 (USD Million)

76. South America Minimal Residual Disease Market, By End-User, 2019-2030 (USD Million)

77. South America Minimal Residual Disease Market, By Test Type, 2019-2030 (USD Million)

78. Brazil Minimal Residual Disease Market, By Detection Target, 2019-2030 (USD Million)

79. Brazil Minimal Residual Disease Market, By Test Technique, 2019-2030 (USD Million)

80. Brazil Minimal Residual Disease Market, By End-User, 2019-2030 (USD Million)

81. Brazil Minimal Residual Disease Market, By Test Type, 2019-2030 (USD Million)

82. Middle East and Africa Minimal Residual Disease Market, By Detection Target, 2019-2030 (USD Million)

83. Middle East and Africa Minimal Residual Disease Market, By Test Technique, 2019-2030 (USD Million)

84. Middle East and Africa Minimal Residual Disease Market, By End-User, 2019-2030 (USD Million)

85. Middle East and Africa Minimal Residual Disease Market, By Test Type, 2019-2030 (USD Million)

86. UAE Minimal Residual Disease Market, By Detection Target, 2019-2030 (USD Million)

87. UAE Minimal Residual Disease Market, By Test Technique, 2019-2030 (USD Million)

88. UAE Minimal Residual Disease Market, By End-User, 2019-2030 (USD Million)

89. UAE Minimal Residual Disease Market, By Test Type, 2019-2030 (USD Million)

90. South Africa Minimal Residual Disease Market, By Detection Target, 2019-2030 (USD Million)

91. South Africa Minimal Residual Disease Market, By Test Technique, 2019-2030 (USD Million)

92. South Africa Minimal Residual Disease Market, By End-User, 2019-2030 (USD Million)

93. South Africa Minimal Residual Disease Market, By Test Type, 2019-2030 (USD Million)

List of Figures 

1. Global Minimal Residual Disease Market Segmentation

2. Global Minimal Residual Disease Market: Research Methodology

3. Market Size Estimation Methodology: Bottom-Up Approach

4. Market Size Estimation Methodology: Top-Down Approach

5. Data Triangulation

6. Porter’s Five Forces Analysis 

7. Value Chain Analysis 

8. Global Minimal Residual Disease Market Attractiveness Analysis By Detection Target  

9. Global Minimal Residual Disease Market Attractiveness Analysis By Test Technique 

10. Global Minimal Residual Disease Market Attractiveness Analysis By End-User

11. Global Minimal Residual Disease Market Attractiveness Analysis By Test Type

12. Global Minimal Residual Disease Market Attractiveness Analysis By Region

13. Global Minimal Residual Disease Market: Dynamics

14. Global Minimal Residual Disease Market Share By Detection Target (2022 & 2030)

15. Global Minimal Residual Disease Market Share By Test Technique (2022 & 2030)

16. Global Minimal Residual Disease Market Share By End-User (2022 & 2030)

17. Global Minimal Residual Disease Market Share By Test Type (2022 & 2030)

18. Global Minimal Residual Disease Market Share By Regions (2022 & 2030)

19. Global Minimal Residual Disease Market Share By Company (2021)

Methodology

Research has its special purpose to undertake marketing efficiently. In this competitive scenario, businesses need information across all industry verticals; the information about customer wants, market demand, competition, industry trends, distribution channels etc. This information needs to be updated regularly because businesses operate in a dynamic environment. Our organization, The Brainy Insights incorporates scientific and systematic research procedures in order to get proper market insights and industry analysis for overall business success. The analysis consists of studying the market from a miniscule level wherein we implement statistical tools which helps us in examining the data with accuracy and precision. 

Our research reports feature both; quantitative and qualitative aspects for any market. Qualitative information for any market research process are fundamental because they reveal the customer needs and wants, usage and consumption for any product/service related to a specific industry. This in turn aids the marketers/investors in knowing certain perceptions of the customers. Qualitative research can enlighten about the different product concepts and designs along with unique service offering that in turn, helps define marketing problems and generate opportunities. On the other hand, quantitative research engages with the data collection process through interviews, e-mail interactions, surveys and pilot studies. Quantitative aspects for the market research are useful to validate the hypotheses generated during qualitative research method, explore empirical patterns in the data with the help of statistical tools, and finally make the market estimations.

The Brainy Insights offers comprehensive research and analysis, based on a wide assortment of factual insights gained through interviews with CXOs and global experts and secondary data from reliable sources. Our analysts and industry specialist assume vital roles in building up statistical tools and analysis models, which are used to analyse the data and arrive at accurate insights with exceedingly informative research discoveries. The data provided by our organization have proven precious to a diverse range of companies, facilitating them to address issues such as determining which products/services are the most appealing, whether or not customers use the product in the manner anticipated, the purchasing intentions of the market and many others.

Our research methodology encompasses an idyllic combination of primary and secondary initiatives. Key phases involved in this process are listed below:

MARKET RESEARCH PROCESS

Data Procurement:

The phase involves the gathering and collecting of market data and its related information with the help of different sources & research procedures.

The data procurement stage involves in data gathering and collecting through various data sources.

This stage involves in extensive research. These data sources includes:

Purchased Database: Purchased databases play a crucial role in estimating the market sizes irrespective of the domain. Our purchased database includes:

• The organizational databases such as D&B Hoovers, and Bloomberg that helps us to identify the competitive scenario of the key market players/organizations along with the financial information.
• Industry/Market databases such as Statista, and Factiva provides market/industry insights and deduce certain formulations. 
• We also have contractual agreements with various reputed data providers and third party vendors who provide information which are not limited to:
• Import & Export Data
• Business Trade Information
• Usage rates of a particular product/service on certain demographics mainly focusing on the unmet prerequisites

Primary Research: The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. Primary research mainly involves in telephonic interviews, E-mail interactions and face-to-face interviews with the raw material providers, manufacturers/producers, distributors, & independent consultants. The interviews that we conduct provides valuable data on market size and industry growth trends prevailing in the market. Our organization also conducts surveys with the various industry experts in order to gain overall insights of the industry/market. For instance, in healthcare industry we conduct surveys with the pharmacists, doctors, surgeons and nurses in order to gain insights and key information of a medical product/device/equipment which the customers are going to usage. Surveys are conducted in the form of questionnaire designed by our own analyst team. Surveys plays an important role in primary research because surveys helps us to identify the key target audiences of the market. Additionally, surveys helps to identify the key target audience engaged with the market. Our survey team conducts the survey by targeting the key audience, thus gaining insights from them. Based on the perspectives of the customers, this information is utilized to formulate market strategies. Moreover, market surveys helps us to understand the current competitive situation of the industry. To be precise, our survey process typically involve with the 360 analysis of the market. This analytical process begins by identifying the prospective customers for a product or service related to the market/industry to obtain data on how a product/service could fit into customers’ lives.

Secondary Research: The secondary data sources includes information published by the on-profit organizations such as World bank, WHO, company fillings, investor presentations, annual reports, national government documents, statistical databases, blogs, articles, white papers and others. From the annual report, we analyse a company’s revenue to understand the key segment and market share of that organization in a particular region. We analyse the company websites and adopt the product mapping technique which is important for deriving the segment revenue. In the product mapping method, we select and categorize the products offered by the companies catering to domain specific market, deduce the product revenue for each of the companies so as to get overall estimation of the market size. We also source data and analyses trends based on information received from supply side and demand side intermediaries in the value chain. The supply side denotes the data gathered from supplier, distributor, wholesaler and the demand side illustrates the data gathered from the end customers for respective market domain.

The supply side for a domain specific market is analysed by:

• Estimating and projecting penetration rates through analysing product attributes, availability of internal and external substitutes, followed by pricing analysis of the product.
• Experiential assessment of year-on-year sales of the product by conducting interviews.

The demand side for the market is estimated through:

• Evaluating the penetration level and usage rates of the product.
• Referring to the historical data to determine the growth rate and evaluate the industry trends

In-house Library: Apart from these third-party sources, we have our in-house library of qualitative and quantitative information. Our in-house database includes market data for various industry and domains. These data are updated on regular basis as per the changing market scenario. Our library includes, historic databases, internal audit reports and archives.

Sometimes there are instances where there is no metadata or raw data available for any domain specific market. For those cases, we use our expertise to forecast and estimate the market size in order to generate comprehensive data sets. Our analyst team adopt a robust research technique in order to produce the estimates:

• Applying demographic along with psychographic segmentation for market evaluation
• Determining the Micro and Macro-economic indicators for each region 
• Examining the industry indicators prevailing in the market. 

Data Synthesis: This stage involves the analysis & mapping of all the information obtained from the previous step. It also involves in scrutinizing the data for any discrepancy observed while data gathering related to the market. The data is collected with consideration to the heterogeneity of sources. Robust scientific techniques are in place for synthesizing disparate data sets and provide the essential contextual information that can orient market strategies. The Brainy Insights has extensive experience in data synthesis where the data passes through various stages:

• Data Screening: Data screening is the process of scrutinising data/information collected from primary research for errors and amending those collected data before data integration method. The screening involves in examining raw data, identifying errors and dealing with missing data. The purpose of the data screening is to ensure data is correctly entered or not. The Brainy Insights employs objective and systematic data screening grades involving repeated cycles of quality checks, screening and suspect analysis.
• Data Integration: Integrating multiple data streams is necessary to produce research studies that provide in-depth picture to the clients. These data streams come from multiple research studies and our in house database. After screening of the data, our analysts conduct creative integration of data sets, optimizing connections between integrated surveys and syndicated data sources. There are mainly 2 research approaches that we follow in order to integrate our data; top down approach and bottom up approach.

Market Deduction & Formulation: The final stage comprises of assigning data points at appropriate market spaces so as to deduce feasible conclusions. Analyst perspective & subject matter expert based holistic form of market sizing coupled with industry analysis also plays a crucial role in this stage.

This stage involves in finalization of the market size and numbers that we have collected from data integration step. With data interpolation, it is made sure that there is no gap in the market data. Successful trend analysis is done by our analysts using extrapolation techniques, which provide the best possible forecasts for the market.

Data Validation & Market Feedback: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helps us finalize data-points to be used for final calculations.

The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. The data validation interview and discussion panels are typically composed of the most experienced industry members. The participants include, however, are not limited to:

• CXOs and VPs of leading companies’ specific to sector
• Purchasing managers, technical personnel, end-users
• Key opinion leaders such as investment bankers, and industry consultants

Moreover, we always validate our data and findings through primary respondents from all the major regions we are working on.